Hatteras Venture Partners

Hatteras Venture Partners, based in Research Triangle Park, North Carolina, focuses on seed and early-stage investments in biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related areas in human medicine. Founded in 2000, the firm has grown significantly and now manages approximately $450 million across multiple funds​. The firm aims to build transformational companies that benefit patients and healthcare professionals, with a strong emphasis on investing in innovative life science companies. Notable investments include G1 Therapeutics, Clearside Biomedical, and GeneCentric​. Hatteras Venture Partners also manages the Venture Capital Multiplier Fund (VCMF), a $60 million fund that co-invests with other venture capital firms to support high-growth companies in North Carolina​. The firm has a proven track record, leveraging relationships with major healthcare institutions like UNC-Chapel Hill, Duke University, and Vanderbilt University to foster innovative startups​.